In a groundbreaking new study, conducted within the framework of the FWF-funded Cluster of Excellence "Microbiomes drive ...

Solengepras is a potentially first-in-class, oral, non-dopaminergic investigational therapy in development for Parkinson’s diseaseARISE will ...

The Medical College of Wisconsin created a neurology department 50 years ago. Today with Froedtert it is world leader in ...

Scientists on the International Space Station (ISS) have grown brain-like organoids in space to research new treatments for ...

Parkinson's disease cases will rise to 3.15 million by 2033. The increase will be seen in seven countries including the US, ...

CHINA: A 70-year-old man from Henan Province in central China has developed Parkinson’s disease after enduring decades of ...

A recently published study by researchers at the University of Arizona Health Sciences found that a tiny protein called PNA5 ...

Insightec received FDA approval for use with Philips MRI scanners. Insightec's Exablate Prime treats essential tremor and ...

Algorithms that can detect subtle changes in a person's voice are emerging as a potential new diagnostic tool for Parkinson's ...

Deep brain stimulation has revealed that a specific type of brain wave activity is associated with levels of anxiety in ...